Skip to main navigation
Advancing Diagnostics to Improve Cancer Treatments Navigation
  • Products
  • Technology
  • Partnership Opportunities
  • Company
  • Contact

Investor Relations

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Email Alerts Subscription
  • Download Library
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

Committee Composition

Independent Director Audit Committee Compensation Committee Nominating and Governance Committee Science and Technology Committee
M. Faye Wilson CPA, MBA Independent Director Audit Committee Compensation Committee Nominating and Governance Committee
Quyen Dao-Haddock Independent Director Audit Committee
Marsha A. Chandler Ph.D. Independent Director Compensation Committee Nominating and Governance Committee Science and Technology Committee
Bruce E Gerhardt CPA Independent Director Audit Committee Compensation Committee
Antonino Morales
Ivor Royston MD Independent Director Nominating and Governance Committee Science and Technology Committee
Samuel D. Riccitelli
Linda Rubinstein Independent Director Compensation Committee Science and Technology Committee
= Independent Director = Chairperson = Member
Investor Relations Company Careers Customer Service
Contact Biocept, Inc.

Biocept, Inc. Headquarters
9955 Mesa Rim Road
San Diego, CA 92121
Phone: 858.320.8200
Fax: 858.320.8225
Email: IR@biocept.com

LHA Investor Relations
Jody Cain
310.691.7107
jcain@lhai.com


  • Careers
  • Company
  • Technology
  • Privacy Policy
  • Terms of Use
  • Contact Us

© 2023 Biocept, Inc. All rights reserved.